- Home
- CLLS vs ACB Comparison
CLLS vs ACB Comparison
Compare CLLS & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- ACB
- Stock Information
- Founded
- CLLS 1999
- ACB 2013
- Country
- CLLS France
- ACB Canada
- Employees
- CLLS N/A
- ACB N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- ACB Pharmaceuticals and Biotechnology
- Sector
- CLLS Health Care
- ACB Health Care
- Exchange
- CLLS Nasdaq
- ACB Nasdaq
- Market Cap
- CLLS 299.0M
- ACB 250.9M
- IPO Year
- CLLS 2007
- ACB N/A
- Fundamental
- Price
- CLLS $3.22
- ACB $4.56
- Analyst Decision
- CLLS Buy
- ACB
- Analyst Count
- CLLS 1
- ACB 0
- Target Price
- CLLS $8.00
- ACB N/A
- AVG Volume (30 Days)
- CLLS 134.5K
- ACB 1.3M
- Earning Date
- CLLS 11-07-2025
- ACB 11-05-2025
- Dividend Yield
- CLLS N/A
- ACB N/A
- EPS Growth
- CLLS N/A
- ACB N/A
- EPS
- CLLS N/A
- ACB N/A
- Revenue
- CLLS $63,438,000.00
- ACB $263,570,704.00
- Revenue This Year
- CLLS N/A
- ACB $9.42
- Revenue Next Year
- CLLS $58.00
- ACB $5.72
- P/E Ratio
- CLLS N/A
- ACB N/A
- Revenue Growth
- CLLS 223.09
- ACB 23.89
- 52 Week Low
- CLLS $1.10
- ACB $3.42
- 52 Week High
- CLLS $5.48
- ACB $6.91
- Technical
- Relative Strength Index (RSI)
- CLLS 41.41
- ACB 37.91
- Support Level
- CLLS $3.12
- ACB $4.26
- Resistance Level
- CLLS $3.79
- ACB $4.83
- Average True Range (ATR)
- CLLS 0.19
- ACB 0.24
- MACD
- CLLS -0.08
- ACB -0.08
- Stochastic Oscillator
- CLLS 13.43
- ACB 27.06
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About ACB Aurora Cannabis Inc.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.